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Abstract
Compressed sensing (CS) reconstructions of under-sampled measurements generate
missing data based on assumptions of image sparsity. Non-contrast time-of-flight MR angi-
ography (TOF-MRA) is a good candidate for CS based acceleration, as MRA images fea-
ture bright trees of sparse vessels over a well-suppressed anatomical background signal.
A short scan time derived from CS is beneficial for patients of moyamoya disease (MMD)
because of the frequency of MR scans. The purpose of this study was to investigate the reli-
ability of TOF-MRA with CS in the evaluation of MMD. Twenty-two patients were examined
using TOF-MRA with CS (CS-TOF) and parallel imaging (PI-TOF). The acceleration factors
were 3 (CS3) and 5 (CS5) for CS-TOF, and 3 (PI3) for PI-TOF. Two neuroradiologists evalu-
ated the MMD grading according to stenosis/occlusion scores using the modified Houkin’s
system, and the visibility of moyamoya vessels (MMVs) using a 3-point scale. Concordance
was calculated with Cohen’s κ. The numbers of MMVs in the basal ganglia were compared
using Bland-Altman analysis and Wilcoxon’s signed-rank tests. MRA scan times were 4:07,
3:53, and 2:42 for PI3, CS3, and CS5, respectively. CS-reconstruction completed within 10
minutes. MMD grading and MMV visibility scales showed excellent correlation (κ > .966).
Although the number of MMVs was significantly higher in CS3 than in PI3 (p < .0001) and
CS5 (p < .0001), Bland-Altman analysis showed a good agreement between PI3, CS3, and
CS5. Compressed sensing can accelerate TOF-MRA with improved visualization of small
collaterals in equivalent time (CS3) or equivalent results in a shorter scan time (CS5).
Introduction
Compressed sensing (CS) has been vigorously studied in recent years because of its potential
to reduce scan time[1] or to improve spatio-temporal resolution while maintaining the same
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scan time[2]. The goal of CS is to approximate the image quality of a fully sampled measure-
ment from under-sampled k-space data, by exploiting the intrinsic sparsity in the imaged
structures in a non-linear iterative regularized reconstruction. Several studies[3,4] on contrast
enhanced MRA with CS have reported on its excellent speed (e.g. only 10 seconds were needed
to cover the whole brain[5]). Non-contrast time-of-flight (TOF) MRA is also a good candidate
for CS based acceleration, as images feature a bright trees of sparse vessels over a well sup-
pressed anatomical background signal[6–10]. In a preceding study on normal volunteers[11],
the scan time of cerebrovascular non-contrast TOF-MRA with CS (CS-TOF) was reduced to
approximately half of that of TOF-MRA with parallel imaging (PI-TOF), the current clinical
standard for accelerating acquisition[12–14], while maintaining the image quality.
CS reconstructions of accelerated (i.e., under-sampled) measurements generate the missing
data by making assumptions about the image sparsity after a certain transformation; in our
case, magnitude images were sparsified in the wavelet domain of the magnitude image. There-
fore, the diagnostic capability of CS-TOF requires validation, especially in regard to whether
or not it introduces an over- or under-estimation of vascular pathological changes in compari-
son with clinically established methods. For cerebrovascular aneurysms, images acquired with
CS-TOF have been successfully evaluated[15,16]. Our aim here is to extend this validation to
vascular stenosis and small vessels.
Moyamoya disease (MMD) is an uncommon cerebrovascular disorder characterized by
progressive stenosis and occlusion of the supra-clinoid internal carotid artery and its main
branches within the circle of Willis. These changes result in the formation of a fine vascular
network, known as the moyamoya vessels (MMVs), and other collateral circulations such as
superficial temporal artery. Visualization of these is directly linked to the surgical treatments
[17]. Although digital subtraction angiography (DSA) still remains the gold standard for the
diagnosis and staging of MMD, TOF-MRA is now considered to be a reliable alternative with
high sensitivity and specificity[18–20]. TOF-MRA is a non-invasive modality that can be read-
ily applied to asymptomatic MMD patients and repeatedly used for follow-up examinations,
even in children.
Therefore, we hypothesized that CS-TOF can be used to assess MMD, and examined the
grading and visualization of MMVs in a prospective MMD cohort, comparing the results from
CS-TOF with those from conventional PI-TOF, with the CS-TOF using the same or a higher
acquisition acceleration factor than the PI-TOF.
Materials and methods
Study population
This study was approved by the local institutional review board (Kyoto University Graduate
School Ethics committee), and written informed consent was obtained from all subjects. From
December 2014 through to October 2015, 22 patients with MMD were enrolled (mean age,
43.1 years; age range, 29–65 years; 14 women and 8 men). All subjects were scanned using
both CS-TOF and PI-TOF in the same session. Diagnosis of MMD was confirmed by DSA or
conventional MRA (PI-TOF). Ten of the patients had undergone a previous operation for
direct bypass from the superficial temporal artery to the middle cerebral artery. Exclusion cri-
teria were failure to acquire the whole imaging sets, as well as large motion and susceptibility
artifacts.
Acquisition of MR angiography
CS-TOF and PI-TOF were acquired using a 3T MR scanner (MAGNETOM Skyra, Siemens
Healthcare, Erlangen, Germany) with a 32-channel head coil (Fig 1). A research sequence and
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reconstruction prototype provided by Siemens Healthcare GmbH (Erlangen, Germany) was
used for CS-TOF. Common acquisition parameters were as follows: TR/TE = 20/3.69 ms,
FA = 18˚, 4 slabs, TONE ramp, 70%; and a reconstructed voxel size of 0.38 × 0.38 × 0.38 mm.
For CS-TOF, the FOV was 220 × 200 × 63 mm and the acquired matrix was 288 × 264 × 82
(interpolated to 576 × 528 × 164), whereas for PI-TOF, the FOV was 240 × 200 × 62 mm, and
the matrix was 320 × 270 × 81 (interpolated to 640 × 540 × 162).
For CS-TOF data acquisition, a conventional 3D TOF gradient-echo sequence was
extended to facilitate incoherent sampling of k-space using a variable-density Poisson disk
sampling pattern in the ky-kz encoding plane on a Cartesian grid[21] (Fig 2). After data acqui-
sition, the image was reconstructed from the under-sampled data by nonlinear iterative
SENSE-type reconstruction[14]. The reconstruction was implemented inline on the scanner.
The following minimization problem is solved using a modified Fast Iterative Shrinkage-



















where x is the image to reconstruct, yj and Sj are the k-space data and coil sensitivity for j-th
coil element, Fu is the Fourier under-sampling operator, W is the redundant Haar wavelet
transform, and λ is the normalized regularization parameter (set to 0.008). This equation and
Fig 1. Coronal views of MIP images. (A) PI3, (B) CS3, (C) CS5. Occlusion of the left MCA and the development of MMVs are
equivalently visualized in these images. PI3, conventional TOF MRA with an acceleration factor of 3; CS3, compressed sensing TOF
MRA with an acceleration factor of 3; CS5, compressed sensing TOF MRA with an acceleration factor of 5; MCA, middle cerebral artery.
https://doi.org/10.1371/journal.pone.0189493.g001
Fig 2. Sampling patterns of the slab. Ky-Kz plane of k-space. (A) Compressed Sensing, (B) Parallel Imaging.
https://doi.org/10.1371/journal.pone.0189493.g002
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the parameter was the same and optimized in our previous study[11]. The image reconstruc-
tion was fully integrated with the scanner software and was performed inline.
The acceleration rates for CS-TOF were 3 (CS3) and 5 (CS5), while that of PI-TOF was 3
(PI3). PI3 (acceleration in phase encoding direction only) was selected as the reference stan-
dard, as it is the acceleration factor in general use in our institution. PI-MRA was recon-
structed with the scanner’s product implementation of GRAPPA (Generalized Auto-
Calibrating Partially Parallel Acquisition) [13,23].
Image analysis
Firstly, two neuroradiologists (T.O. and Y.F., with 26 and 19 years of experience, respectively)
graded the stenotic changes at Circle of Willis on both CS-TOF and PI-TOF. MMD grading
was assessed according to the modified Houkin’s grading system[24]. This classifies the prog-
ress of the disease into 4 grades based on the total stenosis/occlusion scores of internal carotid
artery, middle cerebral artery, anterior cerebral artery, and posterior cerebral artery.
Secondly, MMV visibility was scored using a 3-point scale: 1, few or no MMVs; 2, a moder-
ate amount of MMVs (weak visualization of vessels, but sufficient for diagnosis); 3, a large
amount of MMVs (vessels clearly visualized). Examples are presented in Fig 3.
Thirdly, high-intensity spots recognized as vessels (perforating arteries or MMVs in the
basal ganglia) were manually counted on an original 2D slice at the level of the basal ganglia
by two neuroradiologists (T.Y. and S.O., with 11 and 11 years’ experience, respectively). For
each patient, this was performed separately for the left and right side, with the vessels being
tracked through upper and lower slices to differentiate vessels from noises. Definite vessels
were counted as 1, and probable vessels as 0.5.
Finally, the visibility of bypass vessels was also subjectively evaluated in the 10 patients who
had undergone previous bypass surgery.
All of the analysis above was performed independently, and the sequence was blinded for
the raters.
Statistical analysis
The Cohen’s κ statistic (quadratic weighted) was used to analyzed for the MMD grading and for
the MMV visibility on maximum intensity projection (MIP) images, facilitating comparisons
Fig 3. Moyamoya vessels (MMVs) on MIP images. (A) Few or no MMVs, (B) a moderate amount of MMVs (weak
vessels visibility, but sufficient for diagnosis), (C) a large amount of MMVs (vessels are clearly visualized). All images
are compressed sensing TOF-MRA with an acceleration factor of 3.
https://doi.org/10.1371/journal.pone.0189493.g003
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between CS3, CS5, and PI3 (slight agreement, κ< 0.2; fair agreement, 0.2–0.4; moderate agree-
ment, 0.4–0.6; substantial agreement, 0.6–0.8; almost-perfect agreement,0.8). The MMV
numbers of CS3 and CS5 were compared with PI3 using the Bland-Altman analysis and the Wil-
coxon signed rank test. Inter-rater agreement in the MMV numbers was also evaluated by intra-
class correlation coefficient (ICC). Statistical analyses were performed using R (version 3.3.1,
https://www.r-project.org/), with a p value< .05 being considered as statistically significant.
Results
MRA scan times were 4:07, 3:53 and 2:42 for the PI3, CS3 and CS5 acquisitions, respectively
(Fig 2). The CS-TOF reconstruction was started at the end of the acquisition and finished
within 10 minutes. No patients were excluded from the analysis.
The modified Houkin’s MMD grading of CS3 and CS5 showed a nearly complete agree-
ment with those of PI3 (κ = .993 and .996, respectively; see Table 1), thereby demonstrating
equivalent grading capabilities. Inter-rater agreements were substantial (Table 2).
MMV visibility on CS-TOF MIP images was also equivalent to that on PI-TOF images
(Table 3). Excellent agreements were obtained between PI3 and CS3 (κ = .992), and between
PI3 and CS5 (κ = .967). Inter-rater agreements were substantial (Table 4).
The median number of MMVs at the basal ganglia level was 3 for PI3 (1st–3rd quartile:
2.0–5.3), 4 for CS3 (3.0–6.6), and 3.5 for CS5 (2.0–5.0). The Bland-Altman analysis for the
number of MMVs also showed a good agreement. The number of MMVs on CS3 was signifi-
cantly higher than that on PI3 (p< .0001) or that for CS5 (p< .0001) (Fig 4). No significant
difference was observed between CS5 and PI3 for the number of MMVs. The inter-rater ICC
for counting of the number of MMVs showed an excellent correlation (.894).
Table 1. The results of the MRA grading of moyamoya disease with PI3, CS3, and CS5.
PI3
CS3 (CS5) Stage 1 Stage 2 Stage 3 Stage 4
Stage 1 8 (8)
Stage 2 26 (24)
Stage 3 0 (2) 32 (31)
Stage 4 1 (2) 21 (21)
Two observers independently assessed 44 sides of 22 patients, thus a total of 88 results are illustrated. The κ value was
0.993 between PI3 and CS3, and 0.966 between PI3 and CS5. PI3, conventional TOF MRA with an acceleration factor
of 3; CS3, compressed sensing TOF MRA with an acceleration factor of 3; CS5, compressed sensing TOF MRA with
an acceleration factor of 5.
https://doi.org/10.1371/journal.pone.0189493.t001
Table 2. Inter-rater agreement in the grading score of moyamoya disease observed as Cohen’s κ statistic.
Rater 2
PI3 CS3 CS5
Rater 1 PI3 .755 .751 .765
CS3 .748 .748 .758
CS5 .745 .741 .757
Substantial agreement was shown for each combination of PI3, CS3, and CS5.
PI3, conventional TOF MRA with an acceleration factor of 3; CS3, compressed sensing TOF MRA with an
acceleration factor of 3; CS5, compressed sensing TOF MRA with an acceleration factor of 5.
https://doi.org/10.1371/journal.pone.0189493.t002
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All of the bypass vessels of the patients who had undergone operations were well recognized
in all three acquisitions. The superficial temporal arteries were also satisfyingly depicted in the
other patients.
Discussion
We investigated the diagnostic quality of CS-TOF by evaluating MMD grading (which
include stenosis/occlusion scores) and MMV visibility on both MIP images and 2D slices at
the level of the basal ganglia. CS-TOF better visualized MMVs that work as small collaterals
in an equivalent scan time, and attained equivalent visualization in reduced scan time of less
than 3 minutes.
The choice of an acceleration rate of 3 or 5 for CS-TOF had little effect on the visual aspect
and the grading of MMD, suggesting the absence of either over- or under-estimation due to
irregular undersampling and nonlinear iterative reconstruction. In 4 cases (9.1%), MMD grad-
ing based on CS5 resulted in an over-diagnosis (2 cases, stage 2 as 3; 2 cases, stage 3 as 4; see
Table 1), but we did not observe any cases of under-diagnosis. Thus, if CS-TOF shows a severe
stenosis, a confirmation of the finding using contrast-enhanced angiography (MR, CT, or
DSA) would be worth considering for the initial evaluation, but is not required for follow-up
observations focusing on relative changes. The inter-rater correlation for the stenosis/occlu-
sion scores was substantial; however, the intra-rater agreement was almost perfect. Therefore,
the difference in scoring is considered to reflect variations in evaluation due to the individual
interpreting the images, and this may have contributed to the over diagnoses in the CS5 cases.
The presence and quantity of MMVs is also important for the evaluation of MMD[25–27],
although it is not easy to evaluate it using TOF-MRA[28]. The visibility of MMVs on MIP
images was almost the same on PI-TOF and CS-TOF, whereas the number of MMVs counted
on the CS3 images was significantly higher than that on the PI3 images. This evaluation had
Table 3. The visibility of moyamoya vessels on MIP images from PI3, CS3, and CS5.
PI3
CS3 (CS5) Grade 1 Grade 2 Grade 3
Grade 1 33 (33) 1 (1)
Grade 2 0 (2) 27 (25) 0 (1)
Grade 3 27 (26)
The κ value was 0.992 between PI3 and CS3, and 0.967 between PI3 and CS5.
PI3, conventional TOF MRA with an acceleration factor of 3; CS3, compressed sensing TOF MRA with an
acceleration factor of 3; CS5, compressed sensing TOF MRA with an acceleration factor of 5.
https://doi.org/10.1371/journal.pone.0189493.t003
Table 4. Inter-rater agreement on the visibility of moyamoya vessels observed as Cohen’s κ statistic.
Rater 2
PI3 CS3 CS5
Rater 1 PI3 .608 .608 .608
CS3 .631 .631 .631
CS5 .608 .608 .608
Substantial agreement was shown for each combination of PI3, CS3, and CS5.
PI3, conventional TOF MRA with acceleration factor of 3; CS3, compressed sensing TOF MRA with acceleration
factor of 3; CS5, compressed sensing TOF MRA with acceleration factor of 5.
https://doi.org/10.1371/journal.pone.0189493.t004
Magnetic resonance angiography with compressed sensing for moyamoya disease
PLOS ONE | https://doi.org/10.1371/journal.pone.0189493 January 19, 2018 6 / 11
high intra-observer agreement, with inter-observer reproducibility showing substantial agree-
ment, probably because evaluation on the MIP images is tended to be influenced by observer
subjectivity, as in the evaluation of stenosis/occlusion. The evaluation of the number of MMVs
in basal ganglia helps to understand the difference in characteristics between CS-TOF and
PI-TOF. CS3 showed more MMVs than the others; this is likely to be due to the inherent
denoising effect of CS[1]. CS reconstruction enhances the contrast of vessels by counteracting
background noise, while this denoising effect may also simultaneously diminish signal from
vessels. The previous study reported that the apparent SNR of CS-MRA is higher than that of
PI-MRA with more than 3-fold acceleration[11]. The high apparent SNR is considered to
result in more moyamoya vessels being visualized in CS. In CS3, the positive effect was consid-
ered to exceed the negative effect, while even in CS5, the numbers of MMVs were comparable
with those on PI3. A previous report supports this argument, as it showed that attenuation of
small vessel signals is strong on CS-TOF in comparison with PI-TOF[11].
Fig 5A shows representative images for all three acquisitions. The example PI3 image in Fig
4A shows prominent speckled noise, especially in the center[14,29]; this is due to the g-factor
increase in the center. The example CS images of Fig 5B and 5C show highly reduced noises
throughout the image; however, curved stripe patterns consistent with ghosts originating from
the skull boundaries are apparent, with these becoming most prominent at the center. The
intensity of this artifact varied from slice to slice, but the direction of the stripe patterns always
aligned with the phase encoding direction. We thus speculate that these artifacts are residual
aliasing artifacts originating from the sparse undersampling, possibly derived from the outer
edge of the skull. We evaluated the incoherence by the point spread function of sampling pat-
terns of CS (Fig 6), and the ratio of the main peak of point spread function to the standard
deviation of the pseudo-noise (incoherent artifacts) is 74.2 for CS3, and 35.1 for CS5. The lim-
ited slab size (28 slices, 16.7% oversampling) might constraint the incoherence. Slight patient
movements are also a conceivable reason. Increasing the regularization parameters used in the
reconstruction can mitigate this artifact, but a strong increase may obscure small vessels. How-
ever, this artifact is hardly noticeable on the MIP images (Fig 1), and did not affect the detec-
tion of the vessels in the basal ganglia in this study.
The total reconstruction time for CS was approximately 10 minutes, which is too long for
clinical use. CS-TOF is scanned in 4 slabs in this study, and slab-wise reconstruction after the
Fig 4. Bland-Altman plots and Box-and-whisker plot of the numbers of high-intensities, which are considered as
vessels, observed in the basal ganglia. (A, B) Bland-Altman plots. The Y-axis unit (differences) is numerical. (A) No
significant bias was found comparing PI3 with CS3. (B) Hardly any differences were detected when comparing PI3
with CS5. (C) Box-and-whisker plot. The number for CS3 was significantly higher than that of PI3 (p< .0001) and CS5
(p< .0001). PI3, conventional TOF MRA with an acceleration factor of 3; CS3, compressed sensing TOF MRA with an
acceleration factor of 3; CS5, compressed sensing TOF MRA with an acceleration factor of 5.
https://doi.org/10.1371/journal.pone.0189493.g004
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acquisition of each slab cloud reduce the actual waiting time. Moreover, the reconstruction
time could be drastically shortened to clinically acceptable times by using a graphics processing
unit implementation, which was not available in this study.
There are several limitations to this study. Firstly, CS and PI were separately evaluated for
comparison in this study, however, CS and PI are not essentially exclusive technique, but they
can be used synergistically for further acceleration[30]. Secondly, the acquisition matrix was
not the same between CS-MRA and PI-MRA (voxel size was adjusted to be the same). Setting
the same values for both acquisition matrix and spatial resolution was not feasible due to the
limitation of the sequences at the moment we collected the data. Thirdly, not all patients
underwent DSA. Only 8 subjects had DSA within 6 months before and after examination of
CS-MRA. DSA is invasive, and in the situation where MRI/MRA can depict time-course
changes and offer reliable MMD grading, it is not considered essential. Furthermore, several
studies[31,32] have verified a good correlation between MRA (Houkin’s criteria) and DSA
(Suzuki’s criteria[33]). Fourthly, a relatively small number of patients were assessed, but it is
considered sufficient to elucidate the capability of CS-TOF. Fifthly, only two CS-TOF accelera-
tion rates (3 and 5) were evaluated. The research scans were added to the routine scan, and fur-
ther additions were considered ethically inappropriate because of the burden on the patients.
Fig 5. The 2D slice images at the level of the basal ganglia for (A) PI3, (B) CS3, and (C) CS5. On CS images, some artifacts such as curved
stripe patterns (arrowheads) were seen. These artifacts were not observable on the MIP images. PI3, conventional TOF MRA with an
acceleration factor of 3; CS3, compressed sensing TOF MRA with an acceleration factor of 3; CS5, compressed sensing TOF MRA with an
acceleration factor of 5.
https://doi.org/10.1371/journal.pone.0189493.g005
Fig 6. Point spread functions of the sampling pattern. (A) CS3, (B) CS5. The ratio of the main peak to the standard
deviation of the pseudo-noise (incoherent artifacts) is 74.2 for CS3, and 35.1 for CS5. CS3, compressed sensing TOF
MRA with an acceleration factor of 3; CS5, compressed sensing TOF MRA with an acceleration factor of 5.
https://doi.org/10.1371/journal.pone.0189493.g006
Magnetic resonance angiography with compressed sensing for moyamoya disease
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In conclusion, compressed sensing can accelerate TOF-MRA, while preserving the diagnos-
tic capability for MMD. CS-TOF better visualized collateral MMVs in the equivalent accelera-
tion. Moreover, five-fold accelerated CS-TOF was considered as acceptable for the proper
diagnosis of MMD, allowing detection of steno-occlusive changes and MMVs. Shortening the
scan time without reducing the clinically required coverage and spatial resolution brings bene-
fits to patients, especially those who need to receive repeated life-time follow-up examinations.
Further research is needed to investigate whether even higher acceleration rates can be used
reliably in clinical practice.
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